BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29644967)

  • 21. Can interferon prolong life?
    Esteban R
    Hepatology; 2003 Aug; 38(2):292-4. PubMed ID: 12883472
    [No Abstract]   [Full Text] [Related]  

  • 22. [Standards of hepatitis C treatment. Recommendations of Polish Group of Experts].
    Halota W; Flisiak R; Boroń-Kaczmarska A; Juszczyk J; Cianciara J; Pawłowska M; Simon K; Małkowski P;
    Przegl Epidemiol; 2012; 66(1):83-8. PubMed ID: 22708304
    [No Abstract]   [Full Text] [Related]  

  • 23. Standards of hepatitis C treatment. Recommendations of Polish Group of Experts--2014.
    Halota W; Flisiak R; Boroń-Kaczmarska A; Juszczyk J; Pawłowska M; Simon K; Tomasiewicz K; Małkowski P
    Przegl Epidemiol; 2014; 68(3):469-74, 571-6. PubMed ID: 25394304
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of people diagnosed with chronic hepatitis C virus infection.
    Bulterys M; Sadiq Hamid S
    Bull World Health Organ; 2018 Aug; 96(8):515. PubMed ID: 30104788
    [No Abstract]   [Full Text] [Related]  

  • 25. Towards hepatitis C eradication from the HIV-infected population.
    Barreiro P; Fernandez-Montero JV; de Mendoza C; Labarga P; Soriano V
    Antiviral Res; 2014 May; 105():1-7. PubMed ID: 24534673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of hepatitis B and C worldwide.
    Aggarwal R; Goel A
    BMJ; 2009 Oct; 339():b4431. PubMed ID: 19864363
    [No Abstract]   [Full Text] [Related]  

  • 27. What does it mean to put new hepatitis C drugs on a list of essential medicines?
    Urrutia J; Porteny T; Daniels N
    BMJ; 2016 Apr; 353():i2035. PubMed ID: 27106956
    [No Abstract]   [Full Text] [Related]  

  • 28. Recommendations for the treatment of hepatitis C Polish group of HCV Experts--2015.
    Halota W; Flisiak R; Boroń-Kaczmarska A; Juszczyk J; Pawłowska M; Simon K; Tomasiewicz K; Małkowski P;
    Przegl Epidemiol; 2015; 69(3):515-21, 625-31. PubMed ID: 26519849
    [No Abstract]   [Full Text] [Related]  

  • 29. Adopting more systematic approaches to hepatitis C treatment in correctional facilities.
    Hammett TM
    Ann Intern Med; 2003 Feb; 138(3):235-6. PubMed ID: 12558365
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment and prevention of hepatitis C--progress and challenges. The Danish Society of Hepatology].
    Bukh J; Christensen E; Krogsgaard K
    Ugeskr Laeger; 2003 Mar; 165(12):1233. PubMed ID: 12701283
    [No Abstract]   [Full Text] [Related]  

  • 31. No more excuses: viral hepatitis can be eliminated.
    Locarnini S; Chen DS; Shibuya K
    Lancet; 2016 Apr; 387(10029):1703-4. PubMed ID: 27116263
    [No Abstract]   [Full Text] [Related]  

  • 32. Viral hepatitis C in 2014--the beginning of the end?
    Prelipcean CC; Gogălniceanu P; Mihai C
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):272-8. PubMed ID: 25076687
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of hepatitis C virus infection].
    Zeuzem S
    Praxis (Bern 1994); 2005 May; 94(18):721-6. PubMed ID: 15938383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viral hepatitis C.
    Czepiel J; Biesiada G; Mach T
    Pol Arch Med Wewn; 2008 Dec; 118(12):734-40. PubMed ID: 19202952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C.
    Ahmad J
    BMJ; 2017 Jul; 358():j2861. PubMed ID: 28684552
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of chronic hepatitis C virus infection after liver transplantation.
    Agarwal K; Barnabas A
    Dig Liver Dis; 2013 Sep; 45 Suppl 5():S349-54. PubMed ID: 24091115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pioneering a Global Cure for Chronic Hepatitis C Virus Infection.
    Vilarinho S; Lifton RP
    Cell; 2016 Sep; 167(1):12-15. PubMed ID: 27634325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overview of the viral hepatitis problem.
    Lok AS; Kim WR; El-Serag HB; Maddrey WC
    J Fam Pract; 2010 Apr; 59(4 Suppl):S11-6. PubMed ID: 20398585
    [No Abstract]   [Full Text] [Related]  

  • 39. Host-targeting agents for prevention and treatment of chronic hepatitis C - perspectives and challenges.
    Zeisel MB; Lupberger J; Fofana I; Baumert TF
    J Hepatol; 2013 Feb; 58(2):375-84. PubMed ID: 23041307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current issues in antiviral therapy of chronic hepatitis B and C].
    Bakulin IG
    Eksp Klin Gastroenterol; 2010; (5):3-9. PubMed ID: 20731128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.